The reported resubmission of the New Drug Application will initiate a new evaluation of the treatment’s safety and efficacy for potential FDA ...

For years, the government and the public have been curious about the use of psychedelics for medicine. Beyond typical curiosity though, there have been real developments in recent years as to how to ...

Add Yahoo as a preferred source to see more of our stories on Google. For years, the government and the public have been curious about the use of psychedelics for medicine. Beyond typical curiosity ...

When the VA announced its first-ever MDMA-assisted therapy clinical trial for veterans with PTSD this spring, it was treated, ...

Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for the U.S. rights to an MDMA drug to treat neuropsychiatric disorders. The drug, dubbed ALA-002, is a patented, ...

The use of MDMA for PTSD followed a similar path under the nonprofit MAPS. Its for-profit arm — renamed Lykos Therapeutics, then Resilient Pharmaceuticals last year — received the same status in 2017.

The Departments of Veterans Affairs and Health and Human Services signed an agreement Monday to increase coordination on research into psychedelic drugs for treating veterans’ mental health disorders.

The Food and Drug Administration published its final guidance on psychedelic drug clinical investigations in the Federal Register on Tuesday, providing the most detailed regulatory roadmap this class ...

By Nancy Lapid July 30 (Reuters) - Military veterans with post-traumatic stress disorder who got no relief from conventional ...